Related references
Note: Only part of the references are listed.Association of IFN-γ Signal Transduction Defects with Impaired HLA Class I Antigen Processing in Melanoma Cell Lines
Annedore Respa et al.
CLINICAL CANCER RESEARCH (2011)
T cell recognition of HLA-A2 restricted tumor antigens is impaired by the oncogene HER2
Kousaku Mimura et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Alterations of HLA class I expression in human melanoma xenografts in immunodeficient mice occur frequently and are associated with higher tumorigenicity
Cristina Garrido et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
The escape of cancer from T lymphocytes: immunoselection of MHC class I loss variants harboring structural-irreversible hard lesions
Federico Garrido et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Distinct molecular mechanisms leading to deficient expression of ER-resident aminopeptidases in melanoma
Esther Kamphausen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Myeloid-Derived Suppressor Cells in Human Cancer
Srinivas Nagaraj et al.
CANCER JOURNAL (2010)
Identification of E2F1 as an Important Transcription Factor for the Regulation of Tapasin Expression
Juergen Bukur et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Herpesviruses and immunity: The art of evasion
Bryan D. Griffin et al.
VETERINARY MICROBIOLOGY (2010)
The peptide-loading complex - antigen translocation and MHC class I loading
Christian Schoelz et al.
BIOLOGICAL CHEMISTRY (2009)
Down-regulation of HLA Class I and NKG2D ligands through a concerted action of MAPK and DNA methyltransferases in colorectal cancer cells
Christine Sers et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations
Natalia Aptsiauri et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Molecular mechanisms of MHC class I abnormalities and APM components in human tumors
Barbara Seliger
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Epigenetic Enhancement of Antigen Processing and Presentation Promotes Immune Recognition of Tumors
A. Francesca Setiadi et al.
CANCER RESEARCH (2008)
HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance
M. Campoli et al.
ONCOGENE (2008)
Varicellovirus UL49.5 proteins differentially affect the function of the transporter associated with antigen processing, TAP
Danijela Koppers-Lalic et al.
PLOS PATHOGENS (2008)
Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells
A. Nazmul H. Khan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Epigenetic control of the immune escape mechanisms in malignant carcinomas
A. Francesca Setiadi et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines
Teresa Rodriguez et al.
BMC CANCER (2007)
Expression and genetic analysis of transporter associated with antigen processing in cervical carcinoma
Christine F. W. Vermeulen et al.
GYNECOLOGIC ONCOLOGY (2007)
Defective human leukocyte antigen class I-associated antigen presentation caused by a novel β2-microglobulin loss-of-function in melanoma cells
Chien-Chung Chang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The mutation in the ATP-binding region of JAK1, identified in human uterine leiomyosarcomas, results in defective interferon-γ inducibility of TAP1 and LMP2
T. Hayashi et al.
ONCOGENE (2006)
A rare transporter associated with antigen processing polymorphism overpresented in HLAlow colon cancer reveals the functional significance of the signature domain in antigen processing
TY Yang et al.
CLINICAL CANCER RESEARCH (2005)
Defects in the human leukocyte antigen class I antigen-processing machinery in head and neck squamous cell carcinoma: Association with clinical outcome
M Meissner et al.
CLINICAL CANCER RESEARCH (2005)
Involvement of the chaperone tapasin in HLA-B44 allelic losses in colorectal tumors
CM Cabrera et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Mhc class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma
D Atkins et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Small interfering RNA (siRNA) inhibits the expression of the Her2/neu gene, upregulates HLA class I and induces apoptosis of Her2/neu positive tumor cell lines
A Choudhury et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
HER-2/neu-mediated regulation of components of the MHC class I antigen-processing pathway
F Herrmann et al.
CANCER RESEARCH (2004)
A single-nucleotide deletion leads to rapid degradation of TAP-1 mRNA in a melanoma cell line
TY Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways:: β2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors
CM Cabrera et al.
TISSUE ANTIGENS (2003)
Differential expression of tapasin and immunoproteasome subunits in adenovirus type 5-versus type 12-transformed cells
ACO Vertegaal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas:: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21
I Maleno et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2002)
Downregulation of the constitutive tapasin expression in human tumor cells of distinct origin and its transcriptional upregulation by cytokines
B Seliger et al.
TISSUE ANTIGENS (2001)
Share Paper
